Navigation Links
Bristol-Myers Squibb Board Elects James M. Cornelius Chairman of the Board
Date:2/12/2008

NEW YORK, Feb. 12 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company (NYSE: BMY) today announced that the company's Board of Directors has elected James M. Cornelius chairman of the Board. Mr. Cornelius, who was named chief executive officer in September 2006, will continue serving in that role as well. Mr. Cornelius' current employment contract, which expires in May 2009, will be terminated. The Board also named Lewis B. Campbell, chairman, president and CEO, Textron Inc., as lead independent director. James D. Robinson III, co-founder and general partner, RRE Ventures, resigned as non- executive chairman of the Board, a position he has held since June 2005. He will remain a director of the company until May 6, 2008, the date of the company's Annual Meeting of Stockholders, when he will retire pursuant to the Board's mandatory age retirement policy.

"Speaking for the entire Board, we're delighted that Jim Cornelius will be our next chairman at a critical time when Bristol-Myers Squibb is undergoing a fundamental transformation to a next generation BioPharma company," said Mr. Robinson. "Under Jim's leadership, Bristol-Myers Squibb has been put back on the path of growth, greater profitability and a renewed focus on helping patients prevail over serious diseases. We're confident that as chairman, he and his outstanding leadership team will succeed in their goal of making this a dynamic BioPharma company for the future."

Mr. Cornelius was named CEO of Bristol-Myers Squibb on April 30, 2007, after serving as interim CEO since September 12, 2006. He joined the Board in January 2005.

"I am excited by this tremendous opportunity to serve as chairman of the Board of this great company," said Mr. Cornelius. "Over the past
'/>"/>

SOURCE Bristol-Myers Squibb Company
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
2. Bristol-Myers Squibb to Acquire Adnexus Therapeutics
3. Aureus Pharma Announces Renewal and Expansion of Licensing Agreement With Bristol-Myers Squibb for its AurSCOPE Knowledge Databases
4. Bristol-Myers Squibb and Pierre Fabre Provide Update On Vinflunine Development Status
5. Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community
6. EDS Awarded $715 Million Contract for Bristol-Myers Squibb Information Services
7. Exelixis Submits XL139 Diligence Report to Bristol-Myers Squibb
8. Bristol-Myers Squibb to Announce Results for the Fourth Quarter and Full Year of 2007 on January 31
9. GeneGo Enters Multi-Year Agreement With Bristol Myers Squibb for Access to GeneGo Software Suite and Databases
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. KGI Elects Three New Members to Board of Trustees

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...if., Nov. 6 Calbiotech, Inc. annou...ss Innovative Research (SBIR) Phase I contract by ...d. Under terms of the agreement, Calbiotech will d...agnosis of Dengue virus. ,, Dengue virus is ... threat to military forces deployed to tropical ar...
(Date:11/6/2009)...ov. 6 Intarcia Therapeutics, Inc. ...(DUROS® continuous delivery of exenatide) pro...inth Annual Diabetes Technology Meeting in San Fra...gi-bin/prnh/20050301/SFTU126LOGO ) ,, Continu...0 Lowers Plasma Glucose, HbA1c and Reduces Weight ...
(Date:11/5/2009)...one hybrid . . . , Fuel economy ratings for th...t the www.fueleconomy.gov web site, which Oak Ri...r the U.S. Department of Energy and the U.S. Envir...icles on the best fuel economy list are hybrid ele...ighway). "This list proves that hybrids have gone ...
(Date:11/5/2009)... Nov. 5 The endangered black-foote... U.S. This rare carnivore feeds on prairie dogs. ...and often entire population die-offs in towns occu... implemented a ferret breeding program and has bee...rmerly native habitat. Unfortunately, plague can ...
Breaking Biology Technology:Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2
...e/ - The acceptance of Peros, oral,delivery platfo...significant achievement by Benchmark Biolabs, a fu...irm., Benchmark Biolabs designed, constructed and...s production facility which is co-located on,Bench...in Lincoln, NE., By obtaining approval by the USD...
...il 15 diaDexus, Inc.,today announced the appointm... channel for its new automated PLAC Test for the H...try analyzers to U.S. hospital clinical,laboratori...by the U.S.,Food & Drug Administration (FDA) enabl...istry analyzers., The PLAC Test is the only blood...
...ally enable access to MRI exams for ...ass. and BALTIMORE, April 15 Boston,Scientific Co...privately held,company, today announced a licensin...ce imaging (MRI)-safe technology. Physician implan...devices as a primary unmet clinical,need. Under th...
Other Biology Technology:Another industry first enabled by Benchmark Biolabs - Peros' oral delivery platform and vaccine facility licensed by the USDA 2diaDexus Selects Fisher HealthCare to Sell New Automated PLAC(R) Test 2diaDexus Selects Fisher HealthCare to Sell New Automated PLAC(R) Test 3Boston Scientific and Surgi-Vision Announce Licensing Agreement for MRI-Safe Technology 2Boston Scientific and Surgi-Vision Announce Licensing Agreement for MRI-Safe Technology 3
(Date:11/6/2009)...Monell Center and the Chinese Academy of Sciences ...eting on Taste and Smell Research. Organized by Mo...ll be the first international meeting on taste and...f Executive Officer, American Association for the ...Science magazine, will open the meeting with a ple...
(Date:11/4/2009)...reluctant to officially endorse green tea as a can...about its protective effects, including results of...rch , a journal of the American Association for Ca...al cancer. , Vassiliki Papadimitrakopoulo, M.D....cic/Head and Neck Medical Oncology at the Universi...
(Date:11/4/2009)...ns out, hold the power to help militaries and muni...up toxic waste on test sites. , Compounds known ...k in World War II and have been used in military m... are often used to propel tank shells and act like...creased knowledge of their environmentally harmful...
Breaking Biology News(10 mins):Monell Center joins with CAS to host Beijing meeting on taste and smell research 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2Genomic research will enable greener cleanup of military explosive test sites 2Women underrepresented in most cancer research 48173 1Women underrepresented in most cancer research 48173 2Women underrepresented in most cancer research 48173 3Women underrepresented in most cancer research 48173 4ZigBee Selected by Continua Health Alliance for Next Generation Guidelines 48172 1ZigBee Selected by Continua Health Alliance for Next Generation Guidelines 48172 2ZigBee Selected by Continua Health Alliance for Next Generation Guidelines 48172 3Video 3A CVS pharmacy Kicks Off 8th Annual ALS Fundraising Campaign in Stores Nationwide 48169 1Video 3A CVS pharmacy Kicks Off 8th Annual ALS Fundraising Campaign in Stores Nationwide 48169 2Video 3A CVS pharmacy Kicks Off 8th Annual ALS Fundraising Campaign in Stores Nationwide 48169 3
...the second call for proposals, projects focus on e...e interface between biomedical research and genomi...pproved six RTD-projects today. They will engage a...al Institutes of Technology (ETH Zurich und EPF La..., Lausanne, Geneva and Zurich. The Friedrich-Miesc...
...oup of researchers from the LGC Chemical Metrology...ty of Oviedo, Spain, have come up with a method to...cal element (atoms with an equal number of protons...vary throughout the length of a single hair. The m...ds to track the geographical movements of people, ...
... Rochelle, NY, May 27, 2009New guidelines designed...ent, and monitoring of patients with Medullary Thy...form of thyroid cancer, have been developed by the... ahead of print in Thyroid , a peer-reviewed jour...ertpub.com ). The guidelines are available free on...
Other Biology News:Swiss Initiative in Systems Biology launches new projects 2Sulphur in just one hair could blow a terrorist's alibi 2Sulphur in just one hair could blow a terrorist's alibi 3First comprehensive guidelines for managing medullary thyroid carcinoma published in Thyroid journal 2
Sheep Anti-Methaqualone Polyclonal Antibody, Unconjugated from Abcam
...Product Goat polyclonal to BRF2 Immunogen Synth...erminal amino acids 406-419 of Human BRF2. Reacti...et tested in other species. Background Informatio... polymerase III transcription factor complex requi...
Mouse Anti-Kusabira Orange Monoclonal Antibody, Unconjugated, Clone 2G9 from MBL International
Anti-alpha/beta-Tubulin Antibody, Unconjugated from Cell Signaling Technology
Biology Products: